MAHON PAUL A Insider Trading -- Recent SEC Form 4 Transactions
MAHON PAUL A (CIK 1231589) reported 340 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-19). Recent activity: Buy UTHR (8,300 shares), Sell UTHR (114 shares), Sell UTHR (1,240 shares), Sell UTHR (523 shares), Sell UTHR (378 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 114 | $65,799 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,240 | $689,525 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 523 | $291,552 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 378 | $211,111 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 400 | $223,801 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 197 | $110,445 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 440 | $244,083 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 76 | $42,805 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 69 | $38,946 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 655 | $370,484 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 200 | $113,383 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 300 | $170,585 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 700 | $398,774 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 756 | $431,474 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 464 | $265,311 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 601 | $344,191 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 561 | $321,898 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 192 | $110,353 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 134 | $77,174 |
| 2026-11-19 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 300 | $168,535 |
| 2026-11-05 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Buy | 8,300 | $1.2M |
| 2026-11-05 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 526 | $312,391 |
| 2026-11-05 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,174 | $698,010 |
| 2026-11-05 | UNITED THERAPEUTICS Corp (UTHR) | EVP & GENERAL COUNSEL | Sell | 1,256 | $748,665 |
Source: SEC Form 4 filings · as of 2026-11-19